Scientific Profess

SARS coronavirus 2 is the known cause of coronavirus disease 2019. The "spike" or S protein facilitates viral entry into host cells. Researchers from South Korea, UK & USA, have produced first open-source all-atom models of full-length S protein. bit.ly/2YZfqJu

The 400-patient trial will test Olumiant (baricitinib) – a JAK1/2 inhibitor – in patients admitted to hospital with the SARS-CoV-2 virus who have evidence of inflammation, but don’t require mechanical ventilation. bit.ly/2ADpUpP

Cascade Chemistry, a contract research and manufacturing organisation has been selected to produce the active pharmaceutical ingredient (API) for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for COVID-19 patients. bit.ly/3e65dBa

Survival of coronavirus in different cities, on different surfaces bit.ly/2XUC9ah

Reactive 3D printing for autonomous shapeshifting materials. bit.ly/3hmo1yc

Healthcare marketing comms agency Onyx Health are set to launch a new Interactive Learning Environment (ILE), an online comms tool that aims to transform communication between healthcare professionals and the pharma and med tech industry bit.ly/30zyal3

Danish drugmaker Lundbeck has said it plans to axe up to 160 jobs worldwide as part of a retooling of its R&D operations, with its domestic workforce bearing the brunt of the cuts. bit.ly/3fbVf1c

Researchers have found that the #Kawasaki-like syndrome reported in some children with #coronavirus is actually a new inflammatory condition. bit.ly/2BQQc8b

A Duke University research team has found a small area of the brain in mice that can profoundly control the animals' sense of pain. bit.ly/3gdn1vM

Exploring Operation Warp Speed, the Trump Administration’s program to expedite #ResearchAndDevelopment, manufacturing and distribution of medical countermeasures for #COVID-19. bit.ly/2ASEXf0

Gilead and Galapagos’ JAK inhibitor filgotinib works in patients with ulcerative colitis, but maybe not well enough to displace rival drugs in the class. bit.ly/3edpLYm

.@Roche launch Roche v-TAC, a new digital diagnostic solution allowing clinicians to get arterial blood gas values from patients with respiratory or metabolic abnormalities via a 'simpler, less invasive' venous puncture through use of a digital algorithm. bit.ly/3dV1DJz

Biopharma Exvastat Ltd has won a 3.6 million euro grant from the Innovative Medicines Initiative following its call for developers to repurpose imatinib for the treatment of Acute Respiratory Distress Syndrome (ARDS) induced by COVID-19. bit.ly/2TeuMry

UK-based biotech ILC Therapeutics is working with the University of Oxford to investigate whether the use of evasins – molecules derived from ticks – could offer a new treatment option for patients with COVID-19 with significant lung damage. bit.ly/2AxDA5h

The Cell and Gene Therapy Catapult (CGT Catapult) and Kyoto, Japan-based CiRA Foundation are launching a new collaborative research project focused on induced pluripotent stem (iPS) cell characterisation. bit.ly/2AwQz7f

The NIHR and UK Research and Innovation (UKRI) are calling for new research proposals on the risk factors, transmission and prevalence of the COVID-19 virus SARS-CoV-2. bit.ly/3645Sjt

Genomics England is partnering with the GenOMICC consortium, Illumina and the NHS to launch a new research drive that aims to sequence human genomes to assist in the fight against #coronavirus. bit.ly/3fO9hYg

Analysis work from the MRC-University of Glasgow Centre for Virus Research provides evidence that SARS-CoV-2, the virus that causes #COVID19, has not mutated into different types. bit.ly/3fE0hoj

A new Cleveland Clinic study demonstrates the importance of genetics evaluation and genetic testing for children, adolescents and young adults with solid tumor #cancers. The study was published today in Nature Communications. bit.ly/2YGBhaa

The Joint European Disruptive Initiative (JEDI) has launched a new initiative to bring together the world's scientists for a united attack against the novel #coronavirus pandemic. bit.ly/3dhFmFu